Oral Lamivudine Shows Vision Gains in DME Patients in Early Clinical Trial
Low-cost HIV drug improves visual acuity in diabetic macular edema A decades-old HIV drug is showing fresh promise for a…
Viridian Shares New 52-Week Phase III Trial Data for Active TED
New THRIVE trial data highlight long-term proptosis response with veligrotug in thyroid eye disease patients. Fresh long-term data is showing…
latest posts
